New pharmaceutical products for glaucoma in the pipeline

Article

The drug development pipeline is bursting with new pharmaceutical products that may one day be useful in glaucoma therapy.

Related Videos
Josefina Botta, MD, MSc, at ASCRS 2024
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
J. Morgan Micheletti, MD, speaks at the 2024 ASCRS meeting
Dr William Wiley of Cleveland Eye Clinic, Northeast Ohio
Related Content
A cell in amniotic fluid. Image credit: ©Icruci – stock.adobe.com

Amniotic membrane could move the needle outside of the operating room

April 19th 2024
Article

The tissue serves as a testing ground for outpatient ocular therapies

Concept image for an exhibition hall crowded with people. Image credit: ©arhendrix – stock.adobe.com

Clinicians and researchers don’t shy away from hot topics in the field

April 18th 2024
Article

The 15th annual Congress on Controversies in Ophthalmology heads to Athens, Greece

An elderly woman undergoes an eye exam. Image credit: ©cherryandbees – stock.adobe.com

I-SCREEN programme will use AI and OCT imaging to identify and monitor AMD

April 17th 2024
Article
A patient with a mask has closed eyes. Image credit: ©Ayman Alakhras – stock.adobe.com

Cataract surgery pre-treatment with miLoop: Shorter lensectomy time, less irrigation needed

April 6th 2024
Article

Investigators presented research on the pre-treatment outcomes during the 2024 ASCRS meeting

The ZEISS Meditec logo in front of a graph showing a line up. Image credit: ©piter2121 – stock.adobe.com

Carl Zeiss Meditec AG announces completed acquisition of Dutch Ophthalmic Research Center

April 4th 2024
Article

Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation

Three doors, green, orange and brown, with the numbers 1, 2 and 3 on them. Image created with Canva AI.

Evaluation of an enhanced monofocal intraocular lens

April 3rd 2024
Article

Three IOLs are evaluated in a randomised study

© 2024 MJH Life Sciences

All rights reserved.